St. Jude Children's Research Hospital: Rhabdomyosarcoma trials

The registry lists 17 Rhabdomyosarcoma studies with St. Jude Children's Research Hospital as lead sponsor. 6 are open to participants now and 1 have results posted.

Phase 1 7Phase 2 6No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's LymphomaRecruitingNCT07514819Not applicable
• Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk DiseaseRecruitingNCT06023641Phase 2
• Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing SarcomaRecruitingNCT04901702Phase 1/2
• B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)RecruitingNCT04897321Phase 1
• Familial Investigations of Childhood Cancer PredispositionRecruitingNCT03050268
• Molecular Analysis Of Solid TumorsRecruitingNCT01050296
• Radiation Therapy to Treat Musculoskeletal TumorsActive, not recruitingNCT00186992Phase 2Results posted
• Indocyanine Green (ICG) Guided Tumor ResectionCompletedNCT04084067Phase 1
• Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue SarcomasCompletedNCT02415816Not applicable
• Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified ChemotherapyActive, not recruitingNCT01871766Phase 2
• Effects of Preoperative Physical Therapy in Patients With Lower Extremity MalignancyCompletedNCT01674101Not applicable
• A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and LymphomasCompletedNCT01625351Phase 1
• Markers of Anthracycline-Related Cardiac Muscle InjuryWithdrawnNCT01112800
• Methionine PET/CT Studies In Patients With CancerActive, not recruitingNCT00840047Phase 2
• Everolimus for Treating Pediatric Patients With Recurrent or Refractory TumorsCompletedNCT00187174Phase 1
• Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide ChemotherapyCompletedNCT00187109Phase 1/2
• ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid TumorsCompletedNCT00132158Phase 1